News and Media Coverage

Despite the fact that approximately one in eight men will face a prostate cancer diagnosis, the current standard of screening—the Prostate-Specific Antigen (PSA) test—presents challenges for patients and the healthcare system. In an interview with The Pathologist, Dr. Jason Hafron, [...]

David Tirsell is a beloved local volunteer who has consistently prioritized the care of others over his own needs until he had to battle prostate cancer. Learn about the clinical trial he joined that has been highly effective in restoring [...]

Dr. Jason Hafron recently spoke to Targeted Oncology about an important development in prostate cancer testing to help doctors better understand your risk. There is a blood test for prostate cancer that can help doctors better understand your risk. It's [...]

Becker's interviews Bonnie Greenblatt, Director of Ambulatory Surgical Services at MIU, as part of its discussion on the evolution of ASC ownership models Bonnie Greenblatt, Director of Ambulatory Surgical Services at Michigan Institute of Urology, recently joined Becker's and other ASC [...]

IN THIS INTERVIEW: MIU's Chief Medical Officer and Director of Clinical Research, Jason Hafron, M.D., shares what he believes are some of the most exciting parts of this year's American Urological Association conference: the bladder cancer presentations—specifically, updates on non-muscle-invasive [...]

IN THIS INTERVIEW: MIU's Chief Medical Officer and Director of Clinical Research, Jason Hafron, M.D., discusses the advantages and challenges of recruiting patients for clinical trials for independent medical practices. Read Full Interview

U.S. News & World Report Names Michigan Institute of Urology’s Town Center ASC Among 2025 Best Ambulatory Surgery Centers Detroit, Mich. – April 15, 2025 – Michigan Institute of Urology’s (MIU) Town Center ASC in Troy has been recognized among [...]

Michigan Institute of Urology is a clinical trial site for LEGION-100 Detroit, Mich. (March 31, 2025)—Michigan Institute of Urology (MIU), the largest and most well-established urology practice in Southeast Michigan, has been designated as a clinical trial site to assess [...]

IN THIS INTERVIEW: Jason M. Hafron, MD, CMO, discusses recent approvals in the non–muscle-invasive bladder cancer space and data from several clinical trials evaluating agents for bladder cancer. Hafron is the chief medical officer and medical director of clinical research [...]

TROY, MICH. October 1, 2024—Sweetest Day is October 19, which means men may be struggling to find an appropriate gift. The physicians at Michigan Institute of Urology have an idea: Instead of flowers, how about a vasectomy? If men are [...]

New Public Awareness Effort from Michigan Institute of Urology Troy, Mich. (September 3, 2024) - During September’s Prostate Cancer Awareness Month, the Michigan Institute of Urology wants to stress an important point—0.75. If your prostate-specific antigen (PSA) level increases by [...]

Interventional radiology’s integration with independent urology practices is a growing trend, according to those involved with one such partnership. The latest example is the Michigan Institute of Urology, which is teaming with Prostate Centers USA to open IR Centers at [...]